{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:20:11Z","timestamp":1771708811019,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neuropharm.2019.107736","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T16:24:08Z","timestamp":1565108648000},"page":"107736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism"],"prefix":"10.1016","volume":"162","author":[{"given":"Han-Fang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chia","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po See","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107736_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/sj.emboj.7600126","article-title":"Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD","volume":"23","author":"Ahmadian","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2019.107736_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2019.107736_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41598-018-37570-y","article-title":"Real life experience of medical cannabis treatment in autism: analysis of safety and efficacy","volume":"9","author":"Bar-Lev Schleider","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.107736_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fphar.2018.01521","article-title":"Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and Co-morbidities","volume":"9","author":"Barchel","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib5","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1523\/JNEUROSCI.1617-11.2011","article-title":"Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function","volume":"31","author":"Bateup","year":"2011","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13041-016-0259-6","article-title":"Orchestrated activation of mGluR5 and CB1 promotes neuroprotection","volume":"9","author":"Batista","year":"2016","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2019.107736_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00787-012-0255-z","article-title":"Would some cannabinoids ameliorate symptoms of autism?","volume":"21","author":"Bou Khalil","year":"2012","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107736_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2051-0","article-title":"Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice","volume":"214","author":"Cassano","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nn.2684","article-title":"TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus","volume":"13","author":"Chavez","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1362361315577517","article-title":"The health status of adults on the autism spectrum","volume":"19","author":"Croen","year":"2015","journal-title":"Autism : Int. J. Res. Pract."},{"key":"10.1016\/j.neuropharm.2019.107736_bib11","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1007\/s00213-018-5020-7","article-title":"Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety","volume":"235","author":"Danandeh","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurother. : J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.neuropharm.2019.107736_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1471-4892(02)00014-0","article-title":"Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system","volume":"3","author":"Doherty","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1503\/jpn.160116","article-title":"Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents","volume":"42","author":"Duan","year":"2017","journal-title":"J. Psychiatry Neurosci. : J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1152\/jn.00813.2005","article-title":"Multiple mechanisms of endocannabinoid response initiation in hippocampus","volume":"95","author":"Edwards","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib16","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/emboj.2011.182","article-title":"An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus","volume":"30","author":"Etherton","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2019.107736_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1476-5381.2010.00776.x","article-title":"How important are sex differences in cannabinoid action?","volume":"160","author":"Fattore","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.107736_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib20","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/nn.2685","article-title":"Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens","volume":"13","author":"Grueter","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2019.107736_bib23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/ajcn\/53.5.1312","article-title":"Greater influence of central distribution of adipose tissue on incidence of non-insulin-dependent diabetes in women than men","volume":"53","author":"Haffner","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2019.107736_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2012.01.037","article-title":"Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD","volume":"148","author":"Han","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.107736_bib25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.neuron.2016.11.007","article-title":"SHANK3 deficiency impairs heat hyperalgesia and TRPV1 signaling in primary sensory neurons","volume":"92","author":"Han","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107736_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/embor.2012.187","article-title":"Distinct roles for beta-arrestin 2 and arrestin-domain-containing proteins in beta 2 adrenergic receptor trafficking","volume":"14","author":"Han","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuropharm.2019.107736_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.physiol.010908.163149","article-title":"Endocannabinoid signaling and long-term synaptic plasticity","volume":"71","author":"Heifets","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/187152709789824624","article-title":"The endocannabinoid system and the treatment of mood and anxiety disorders","volume":"8","author":"Hill","year":"2009","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2019.107736_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0026-895X(25)10219-8","article-title":"Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs","volume":"29","author":"Howlett","year":"1986","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2019.107736_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.107736_bib32","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.107736_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phrs.2016.08.033","article-title":"Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid","volume":"113","author":"Kerr","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2019.107736_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","article-title":"Alterations in the endocannabinoid system in the rat valproic acid model of autism","volume":"249","author":"Kerr","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107736_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuron.2009.01.015","article-title":"Synaptic AMPA receptor plasticity and behavior","volume":"61","author":"Kessels","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107736_bib36","doi-asserted-by":"crossref","first-page":"20955","DOI":"10.1073\/pnas.0710548105","article-title":"Amygdala depotentiation and fear extinction","volume":"104","author":"Kim","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41386-018-0098-5","article-title":"Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism","volume":"44","author":"Kim","year":"2019","journal-title":"Neuropsychopharmacology : Off. Publ. Am. College Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2019.107736_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6","article-title":"Long-term memory underlying hippocampus-dependent social recognition in mice","volume":"10","author":"Kogan","year":"2000","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2019.107736_bib40","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1097\/j.pain.0000000000001027","article-title":"Age-dependent plasticity in endocannabinoid modulation of pain processing through postnatal development","volume":"158","author":"Kwok","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2019.107736_bib41","first-page":"E1575","article-title":"Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib42","article-title":"The amygdala excitatory\/inhibitory balance in a valproate-induced rat autism model","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107736_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7120158","article-title":"Binge alcohol exposure transiently changes the endocannabinoid system: a potential target to prevent alcohol-induced neurodegeneration","volume":"7","author":"Liput","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/npp.2010.19","article-title":"Abnormal mGlu 5 receptor\/endocannabinoid coupling in mice lacking FMRP and BC1 RNA","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Neuropsychopharmacology : Off. Publ. Am. College Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(00)81067-3","article-title":"Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization","volume":"25","author":"Man","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107736_bib46","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1523\/JNEUROSCI.3516-16.2017","article-title":"Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acid imbalance","volume":"37","author":"Manduca","year":"2017","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.107736_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0269881111408459","article-title":"The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives","volume":"26","author":"Marco","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2011.01.044","article-title":"Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system","volume":"220","author":"Marco","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107736_bib49","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.psyneuen.2013.04.004","article-title":"Emotional, endocrine and brain anandamide response to social challenge in infant male rats","volume":"38","author":"Marco","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fncel.2014.00023","article-title":"Late onset deficits in synaptic plasticity in the valproic acid rat model of autism","volume":"8","author":"Martin","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2007.04.014","article-title":"Role of the cyclic-AMP\/PKA cascade and of P\/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens","volume":"54","author":"Mato","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib52","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"Melancia","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib53","first-page":"3276","article-title":"Hub and switches: endocannabinoid signalling in midbrain dopamine neurons","volume":"367","author":"Melis","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2007.07.005","article-title":"Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors","volume":"54","author":"Moreira","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13229-015-0024-1","article-title":"Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autism","volume":"6","author":"Mottron","year":"2015","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2019.107736_bib56","doi-asserted-by":"crossref","first-page":"15537","DOI":"10.1073\/pnas.0707484104","article-title":"Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors","volume":"104","author":"Nakamoto","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1476-5381.2012.02028.x","article-title":"Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system","volume":"167","author":"Okine","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neures.2017.05.007","article-title":"Social memory engram in the hippocampus","volume":"129","author":"Okuyama","year":"2018","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2019.107736_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2016.06.035","article-title":"Increased anxiety-like behaviour and altered GABAergic system in the amygdala and cerebellum of VPA rats - an animal model of autism","volume":"629","author":"Olexova","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2019.107736_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.107736_bib61","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1523\/JNEUROSCI.4033-07.2008","article-title":"Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons","volume":"28","author":"Pan","year":"2008","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.107736_bib62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2013.01.003","article-title":"Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction","volume":"138","author":"Panlilio","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2019.107736_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1742-2094-10-20","article-title":"Molecular evidence for the involvement of PPAR-delta and PPAR-gamma in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma","volume":"10","author":"Paterniti","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2019.107736_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2019.107736_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001627","article-title":"Reduced juvenile long-term depression in tuberous sclerosis complex is mitigated in adults by compensatory recruitment of mGluR5 and Erk signaling","volume":"11","author":"Potter","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib66","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/WNL.57.9.1618","article-title":"Postmortem brain abnormalities of the glutamate neurotransmitter system in autism","volume":"57","author":"Purcell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.pcl.2008.07.005","article-title":"Autism: definition, neurobiology, screening, diagnosis","volume":"55","author":"Rapin","year":"2008","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.neuropharm.2019.107736_bib68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/tera.1420350107","article-title":"Teratogenicity of di(2-ethylhexyl) phthalate, 2-ethylhexanol, 2-ethylhexanoic acid, and valproic acid, and potentiation by caffeine","volume":"35","author":"Ritter","year":"1987","journal-title":"Teratology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib69","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1073\/pnas.122149199","article-title":"Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens","volume":"99","author":"Robbe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei","volume":"370","author":"Rodier","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib71","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2019.107736_bib72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-pathol-011811-132457","article-title":"Molecular mechanisms of fragile X syndrome: a twenty-year perspective","volume":"7","author":"Santoro","year":"2012","journal-title":"Annual review of pathology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib74","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib75","doi-asserted-by":"crossref","first-page":"H992","DOI":"10.1152\/ajpheart.00870.2003","article-title":"Anandamide content and interaction of endocannabinoid\/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition","volume":"286","author":"Seagard","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.182","article-title":"Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid","volume":"6","author":"Servadio","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107736_bib77","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev.cellbio.23.090506.123516","article-title":"The cell biology of synaptic plasticity: AMPA receptor trafficking","volume":"23","author":"Shepherd","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib78","doi-asserted-by":"crossref","first-page":"18150","DOI":"10.1073\/pnas.1113444108","article-title":"The major central endocannabinoid directly acts at GABA(A) receptors","volume":"108","author":"Sigel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib79","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrn3937","article-title":"Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy","volume":"16","author":"Soltesz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107736_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060040","article-title":"Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism","volume":"8","author":"Starowicz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107736_bib81","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1073\/pnas.1222803110","article-title":"Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism","volume":"110","author":"Takeuchi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-007-1025-3","article-title":"Bidirectional cannabinoid modulation of social behavior in adolescent rats","volume":"197","author":"Trezza","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107736_bib83","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/jpet.108.141069","article-title":"Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats","volume":"328","author":"Trezza","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.107736_bib84","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","article-title":"Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats","volume":"32","author":"Trezza","year":"2012","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.107736_bib85","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2009.06.020","article-title":"Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors","volume":"33","author":"Umathe","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107736_bib86","doi-asserted-by":"crossref","first-page":"52908","DOI":"10.1155\/2007\/52908","article-title":"Endocannabinoid system and synaptic plasticity: implications for emotional responses","volume":"2007","author":"Viveros","year":"2007","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2019.107736_bib87","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI87997","article-title":"Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism","volume":"127","author":"Wang","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2019.107736_bib88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2015.0008","article-title":"Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment","volume":"1","author":"Wei","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neuropharm.2019.107736_bib89","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1007\/s12035-016-0074-1","article-title":"Alleviation of N-Methyl-D-Aspartate receptor-dependent long-term depression via regulation of the glycogen synthase kinase-3 beta pathway in the amygdala of a valproic acid-induced animal model of autism","volume":"54","author":"Wu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib90","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1007\/s12035-017-0685-1","article-title":"D-cycloserine ameliorates autism-like deficits by removing glua2-containing AMPA receptors in a valproic acid-induced rat model","volume":"55","author":"Wu","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib91","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0708349105","article-title":"Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus","volume":"105","author":"Yasuda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107736_bib92","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jfma.2011.09.002","article-title":"Food safety involving ingestion of foods and beverages prepared with phthalate-plasticizer-containing clouding agents","volume":"110","author":"Yen","year":"2011","journal-title":"J. Formos. Med. Assoc. = Taiwan Yi Zhi"},{"key":"10.1016\/j.neuropharm.2019.107736_bib93","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1152\/jn.00491.2010","article-title":"Endocannabinoid-dependent LTD in a nociceptive synapse requires activation of a presynaptic TRPV-like receptor","volume":"104","author":"Yuan","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2019.107736_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:58:43Z","timestamp":1758437923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819302953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":94,"alternative-id":["S0028390819302953"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107736","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107736"}}